Table 13.
Data showing comparison of the proposed system and FRS of random testing on different experimental values
| Parameters used for comparison of proposed system and FRS (patient record)
|
Manually equated/calculated desired result
|
Desired result based on doctor’s diagnosis | Result and accuracy of proposed QNN based system
|
% accuracy QNN | Accuracy group-wise | Result FRS | % accuracy FRS | Accuracy group-wise | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (Years) | Sex | TC (mmol/L) | HDL (mmol/L) | Smoker | SBP (mmHg) | Medication | Output | Risk category | Output | Risk category | ||||||
| 40 | Male | 4.20 | 2.20 | No | 117 | Yes | 18.75% | Normal | Normal | 18.71% | Normal | 99.79 | 99.94 | 0.99 | 5.28 | 19.60 |
| 35 | Female | 5.00 | 1.81 | No | 121 | Yes | 37.50% | Low risk | Low risk | 37.50% | Low risk | 100.00 | 0.77 | 2.04 | ||
| 55 | Female | 5.28 | 1.68 | No | 132 | Yes | 43.75% | Low risk | Low risk | 43.75% | Low risk | 100.00 | 6.32 | 14.44 | ||
| 45 | Male | 5.28 | 1.68 | Yes | 126 | Yes | 43.75% | Low risk | Low risk | 43.70% | Low risk | 99.89 | 9.45 | 21.60 | ||
| 70 | Male | 5.83 | 1.42 | No | 140 | Yes | 56.25% | Intermediate risk | Intermediate risk | 56.22% | Intermediate risk | 99.95 | 27.71 | 49.26 | ||
| 65 | Female | 4.74 | 1.94 | No | 135 | Yes | 31.25% | Low risk | Low risk | 31.24% | Low risk | 99.97 | 8.34 | 26.70 | ||
| 45 | Male | 7.17 | 0.78 | No | 190 | Yes | 87.50% | Highest risk | Highest risk | 87.50% | Highest risk | 100.00 | 15.64 | 17.87 | ||
| 60 | Male | 5.28 | 1.68 | No | 132 | Yes | 43.75% | Low risk | Low risk | 43.70% | Low risk | 99.89 | 99.96 | 13.49 | 30.83 | 20.49 |
| 50 | Male | 6.37 | 1.17 | Yes | 134 | Yes | 68.75% | Intermediate risk | Intermediate risk | 68.76% | Intermediate risk | 100.01 | 23.37 | 33.99 | ||
| 60 | Female | 4.20 | 2.20 | No | 130 | Yes | 18.75% | Normal | Normal | 18.76% | Normal | 100.05 | 4.50 | 24.00 | ||
| 25 | Male | 6.37 | 1.17 | Yes | 126 | Yes | 68.75% | Intermediate risk | Intermediate risk | 68.76% | Intermediate risk | 100.01 | 1.68 | 2.44 | ||
| 60 | Male | 4.20 | 2.20 | No | 126 | Yes | 18.75% | Normal | Normal | 18.71% | Normal | 99.79 | 7.43 | 39.60 | ||
| 20 | Female | 7.74 | 0.65 | No | 160 | No | 93.75% | Highest risk | Highest risk | 93.75% | Highest risk | 100.00 | 0.92 | 0.99 | ||
| 35 | Male | 6.63 | 1.04 | Yes | 129 | Yes | 75.00% | Intermediate risk | Intermediate risk | 75.00% | Intermediate risk | 100.00 | 8.67 | 11.57 | ||
| 60 | Male | 8.29 | 0.52 | No | 190 | Yes | 100.00% | Highest risk | Highest risk | 100.00% | Highest risk | 100.00 | 99.97 | 46.52 | 46.52 | 30.57 |
| 60 | Female | 7.74 | 0.65 | No | 180 | Yes | 93.75% | Highest risk | Highest risk | 93.75% | Highest risk | 100.00 | 31.23 | 33.32 | ||
| 25 | Female | 8.29 | 0.52 | No | 165 | Yes | 100.00% | Highest risk | Highest risk | 100.00% | Highest risk | 100.00 | 3.65 | 3.65 | ||
| 25 | Male | 5.83 | 1.42 | Yes | 123 | Yes | 56.25% | Intermediate risk | Intermediate risk | 56.22% | Intermediate risk | 99.95 | 1.00 | 1.79 | ||
| 45 | Male | 5.83 | 1.42 | No | 129 | No | 56.25% | Intermediate risk | Intermediate risk | 56.22% | Intermediate risk | 99.95 | 6.26 | 11.13 | ||
| 65 | Female | 7.74 | 0.65 | No | 170 | Yes | 93.75% | Highest risk | Highest risk | 93.75% | Highest risk | 100.00 | 35.44 | 37.81 | ||
| 70 | Male | 5.28 | 1.68 | Yes | 136 | Yes | 43.75% | Low risk | Low risk | 43.70% | Low risk | 99.89 | 34.89 | 79.74 | ||
| 40 | Female | 4.74 | 1.94 | No | 125 | Yes | 31.25% | Low risk | Low risk | 31.25% | Low risk | 100.00 | 99.97 | 1.26 | 4.04 | 15.77 |
| 65 | Female | 6.37 | 1.17 | No | 145 | Yes | 68.75% | Intermediate risk | Intermediate risk | 68.76% | Intermediate risk | 100.01 | 20.08 | 29.20 | ||
| 45 | Female | 5.00 | 1.81 | No | 122 | Yes | 37.50% | Low risk | Low risk | 37.50% | Low risk | 100.00 | 2.16 | 5.75 | ||
| 25 | Male | 5.28 | 1.68 | No | 120 | Yes | 43.75% | Low risk | Low risk | 43.70% | Low risk | 99.89 | 0.17 | 0.39 | ||
| 40 | Female | 6.09 | 1.30 | No | 125 | Yes | 62.50% | Intermediate risk | Intermediate risk | 62.50% | Intermediate risk | 100.00 | 3.08 | 4.93 | ||
| 40 | Male | 7.74 | 0.65 | Yes | 160 | No | 93.75% | Highest risk | Highest risk | 93.73% | Highest risk | 99.98 | 24.33 | 25.96 | ||
| 65 | Male | 5.28 | 1.68 | No | 134 | Yes | 43.75% | Low risk | Low risk | 43.70% | Low risk | 99.89 | 17.55 | 40.10 | ||
| 65 | Male | 3.65 | 2.46 | Yes | 124 | Yes | 6.25% | Normal | Normal | 6.25% | Normal | 100.00 | 99.90 | 14.53 | 23.25 | 31.00 |
| 55 | Male | 6.09 | 1.30 | Yes | 134 | Yes | 62.50% | Intermediate risk | Intermediate risk | 62.50% | Intermediate risk | 100.00 | 26.34 | 42.15 | ||
| 65 | Female | 5.54 | 1.55 | No | 140 | Yes | 50.00% | Low risk | Low risk | 49.80% | Low risk | 99.60 | 13.11 | 26.21 | ||
| 55 | Male | 4.20 | 2.20 | No | 123 | No | 18.75% | Normal | Normal | 18.71% | Normal | 99.79 | 5.00 | 26.67 | ||
| 55 | Male | 6.92 | 0.91 | No | 139 | Yes | 81.25% | Highest risk | Highest risk | 81.26% | Highest risk | 100.01 | 23.89 | 29.40 | ||
| 45 | Male | 8.29 | 0.52 | Yes | 170 | No | 100.00% | Highest risk | Highest risk | 100.00% | Highest risk | 100.00 | 38.31 | 38.31 | ||
| 20 | Male | 8.29 | 0.52 | No | 160 | Yes | 100.00% | Highest risk | Highest risk | 100.00% | Highest risk | 100.00 | 98.36 | 1.10 | 1.10 | 13.96 |
| 35 | Male | 8.29 | 0.52 | Yes | 175 | Yes | 100.00% | Highest risk | Highest risk | 99.96% | Highest risk | 99.96 | 21.32 | 21.32 | ||
| 55 | Female | 5.83 | 1.42 | No | 135 | Yes | 56.25% | Intermediate risk | Intermediate risk | 50.75% | Low risk | 90.22 | 8.85 | 15.74 | ||
| 30 | Female | 4.74 | 1.94 | No | 115 | No | 31.25% | Low risk | Low risk | 31.25% | Low risk | 100.00 | 0.24 | 0.78 | ||
| 50 | Male | 7.74 | 0.65 | Yes | 175 | No | 93.75% | Highest risk | Highest risk | 93.73% | Highest risk | 99.98 | 40.08 | 42.75 | ||
| 35 | Female | 5.28 | 1.68 | No | 120 | Yes | 43.75% | Low risk | Low risk | 43.75% | Low risk | 100.00 | 0.91 | 2.07 | ||
| 60 | Female | 4.45 | 2.07 | No | 130 | Yes | 25.00% | Normal | Normal | 25.01% | Normal | 100.04 | 99.99 | 5.17 | 20.69 | 17.02 |
| 55 | Female | 3.91 | 2.33 | No | 125 | Yes | 12.50% | Normal | Normal | 12.50% | Normal | 100.00 | 2.52 | 20.14 | ||
| 60 | Male | 6.92 | 0.91 | Yes | 160 | Yes | 81.25% | Highest risk | Highest risk | 81.26% | Highest risk | 100.01 | 44.34 | 54.57 | ||
| 40 | Male | 4.74 | 1.94 | No | 120 | Yes | 31.25% | Low risk | Low risk | 31.21% | Low risk | 99.87 | 1.57 | 5.02 | ||
| 50 | Male | 4.45 | 2.07 | No | 123 | Yes | 25.00% | Normal | Normal | 25.00% | Normal | 100.00 | 3.93 | 15.71 | ||
| 35 | Female | 3.65 | 2.46 | No | 110 | Yes | 6.25% | Normal | Normal | 6.25% | Normal | 100.00 | 0.17 | 2.75 | ||
| 25 | Female | 4.20 | 2.20 | No | 110 | Yes | 18.75% | Normal | Normal | 18.75% | Normal | 100.00 | 0.04 | 0.24 | ||
| 20 | Female | 4.20 | 2.20 | No | 110 | Yes | 18.75% | Normal | Normal | 18.75% | Normal | 100.00 | 99.28 | 0.01 | 0.06 | 13.85 |
| 50 | Female | 4.45 | 2.07 | No | 125 | Yes | 25.00% | Normal | Normal | 24.01% | Normal | 96.04 | 2.47 | 9.90 | ||
| 40 | Female | 6.37 | 1.17 | No | 129 | Yes | 68.75% | Intermediate risk | Intermediate risk | 68.75% | Intermediate risk | 100.00 | 4.10 | 5.97 | ||
| 65 | Male | 6.92 | 0.91 | No | 175 | No | 81.25% | Highest risk | Highest risk | 81.26% | Highest risk | 100.01 | 36.06 | 44.38 | ||
| 55 | Male | 3.91 | 2.33 | No | 121 | Yes | 12.50% | Normal | Normal | 12.50% | Normal | 100.00 | 4.10 | 32.78 | ||
| 25 | Female | 6.37 | 1.17 | No | 125 | Yes | 68.75% | Intermediate risk | Intermediate risk | 68.00% | Intermediate risk | 98.91 | 0.60 | 0.87 | ||
| 40 | Female | 4.45 | 2.07 | No | 115 | Yes | 25.00% | Normal | Normal | 25.00% | Normal | 100.00 | 0.75 | 2.99 | ||
| 30 | Female | 5.83 | 1.42 | No | 120 | Yes | 56.25% | Intermediate risk | Intermediate risk | 56.25% | Intermediate risk | 100.00 | 99.97 | 0.71 | 1.26 | 14.90 |
| 60 | Male | 5.54 | 1.55 | No | 134 | Yes | 50.00% | Low risk | Low risk | 50.00% | Low risk | 100.00 | 15.57 | 31.14 | ||
| 50 | Male | 6.92 | 0.91 | Yes | 190 | Yes | 81.25% | Highest risk | Highest risk | 81.26% | Highest risk | 100.01 | 30.24 | 37.22 | ||
| 50 | Female | 6.63 | 1.04 | No | 180 | Yes | 75.00% | Intermediate risk | Intermediate risk | 75.00% | Intermediate risk | 100.00 | 11.20 | 14.94 | ||
| 35 | Male | 4.20 | 2.20 | No | 116 | Yes | 18.75% | Normal | Normal | 18.71% | Normal | 99.79 | 0.46 | 2.46 | ||
| 55 | Female | 4.45 | 2.07 | No | 124 | Yes | 25.00% | Normal | Normal | 25.00% | Normal | 100.00 | 3.36 | 13.46 | ||
| 35 | Female | 6.63 | 1.04 | No | 160 | Yes | 75.00% | Intermediate risk | Intermediate risk | 75.00% | Intermediate risk | 100.00 | 2.87 | 3.82 | ||
| 20 | Male | 5.83 | 1.42 | Yes | 122 | Yes | 56.25% | Intermediate risk | Intermediate risk | 56.22% | Intermediate risk | 99.95 | 99.98 | 0.28 | 0.49 | 15.05 |
| 55 | Female | 6.63 | 1.04 | No | 140 | No | 75.00% | Intermediate risk | Intermediate risk | 75.00% | Intermediate risk | 100.00 | 14.64 | 19.52 | ||
| 70 | Male | 6.92 | 0.91 | Yes | 180 | Yes | 81.25% | Highest risk | Highest risk | 81.26% | Highest risk | 100.01 | 56.33 | 69.33 | ||
| 40 | Female | 5.54 | 1.55 | No | 126 | Yes | 50.00% | Low risk | Low risk | 50.00% | Low risk | 100.00 | 2.21 | 4.42 | ||
| 45 | Female | 4.74 | 1.94 | No | 120 | Yes | 31.25% | Low risk | Low risk | 31.23% | Low risk | 99.94 | 1.72 | 5.50 | ||
| 25 | Female | 4.74 | 1.94 | No | 115 | Yes | 31.25% | Low risk | Low risk | 31.25% | Low risk | 100.00 | 0.09 | 0.30 | ||
| 30 | Male | 3.65 | 2.46 | Yes | 112 | No | 6.25% | Normal | Normal | 6.25% | Normal | 100.00 | 0.36 | 5.75 | ||
Abbreviations: TC, total cholesterol; HDL, high density lipoprotein; SBP, systolic blood pressure; QNN, quantum neural network; FRS, Framingham risk score.